SearchSearach Website
Close Searach

Search Website

A

Larger Smaller

A

Living Well With Low Vision Sponsored by Prevent Blindness
  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate
Skip to content
Skip to content

Living Well With Low Vision

  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate

News & Archive Categories

    Month: November 2020

    Beware UVC Lamps as COVID-19 Disinfectant

    Posted on November 26, 2020November 26, 2020 by Dan Roberts
  • November 26, 2020

    Beware UVC Lamps as COVID-19 Disinfectant

    Since the outbreak of COVID-19 disease, consumers’ interest in ultraviolet-C (UVC) lamps has increased for use in disinfecting surfaces in the home or similar spaces. The U.S. Food and Drug Administration (FDA) has received reports of skin and eye burns resulting from improper use or installation of UVC lamps. Such lamps fall into four categories: […]

      Also posted in
    • Daily Living
    • Eye Conditions
  • How well are you adapting to visual impairment?

    Posted on November 21, 2020November 21, 2020 by Dan Roberts
  • November 21, 2020

    How well are you adapting to visual impairment?

    How can you tell if you are adapting as well as possible to the most important facets of your everyday life?  A new self-survey is helping visually impaired and blind individuals score how well they are adapting. It is similar to a needs assessment questionnaire used by rehabilitation specialists, but it is designed for self- […]

      Also posted in
    • Daily Living
    • Latest News
    • Low Vision Rehabilitation
  • Lucentis Substitute In Phase 3 Trials

    Posted on November 15, 2020November 15, 2020 by Dan Roberts
  • November 15, 2020

    Lucentis Substitute In Phase 3 Trials

    Samsung Bioepis is reporting first year results from their phase 3 study of a proposed lucentis biosimilar (SB11).  A biosimilar is a biological product (derived from a living organism)  that shows no clinically meaningful differences from another biologic (eg. Lucentis). This study has shown that, at 52 weeks, primary end points were met for visual […]

      Also posted in
    • Latest News
    • Research and Developments
Some Like it Neat, by Alex Vasquez
© All Rights Reserved
Footer Content Right

Receive News and Updates


 

We look to your generosity to support Prevent Blindness and keep our resources up to date.

Donate Now
  • Facebook
  • Twitter
Privacy Policy
Prevent Blindness

© 2018 Prevent Blindness. All rights reserved.